AABIVXX

ETF / Mutual Fund
NASDAQ
Barclays Bank PLC Capped Point to Point Buffer Note AABIVXX
Healthcare
Price Chart
Overview

About AABIVXX

A clinical-stage biotechnology company developing therapeutics to stabilize immune responses in chronic inflammatory diseases.

AUM
$376.5M
Volume
Avg. Volume
Expense Ratio

Top Holdings

Other
100.00%

Sector Allocation

Other100.00%

Country Allocation

Other100.00%

Fund Information

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Latest News for AABIVXX
Risk & Correlation Analysis
Market Correlation
0.00
Low Correlation
Volatility
Low (0.00)
Relative to market
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for AABIVXX.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, AABIVXX shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
AUM$376.5M
Volume
Expense Ratio
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how AABIVXX fits into your investment strategy and portfolio diversification.

Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025